^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners
    DRUG:

    istiratumab (MM-141)

    i
    Associations
    News

    Trials

    Company:
    Ipsen
    Drug class:
    HER3 inhibitor, IGF-1R inhibitor
    Related drugs:
    Associations
    News

    Trials

    Apply
    A Phase 2 Study of MM-141 Plus Nab-paclitaxel and Gemcitabine in Front-line Metastatic Pancreatic Cancer (CARRIE) (NCT02399137)
    Phase 2
    Merrimack Pharmaceuticals
    Completed
    Last update posted :
    09/18/2018
    Initiation :
    05/01/2015
    Primary completion :
    08/01/2018
    Completion :
    08/01/2018
    IGF1
    |
    gemcitabine • albumin-bound paclitaxel • istiratumab (MM-141)